The Capio Prostate Cancer Center Model for Prostate Cancer Diagnostics—Real-world Evidence from 2018 to 2022

The Capio Prostate Cancer Center Model for Prostate Cancer Diagnostics—Real-world Evidence from 2018 to 2022

Background: The Capio Prostate Cancer Center (Capio PCC) in Stockholm, Sweden, adopts a comprehensive diagnostic approach, utilizing prostate-specific antigen (PSA), Stockholm3, and magnetic resonance imaging (MRI) for prostate cancer risk assessment, followed by targeted and systematic biopsies for...

Full description

Bibliographic Details
Main Authors: Thorgerdur Palsdottir, Harald Söderbäck, Fredrik Jäderling, Martin Bergman, Hari Vigneswaran, Henrik Grönberg
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:European Urology Open Science
Subjects:
Prostate cancer
Risk prediction
Prostate cancer risk
Prostate-specific antigen
Stockholm3
Prostate cancer diagnostics
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168324002222

Internet

http://www.sciencedirect.com/science/article/pii/S2666168324002222

Similar Items